ATC Group: A05BA Liver therapy

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A05BA in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Bile and liver therapy
3
Liver therapy, lipotropics
4
A05BA
Liver therapy

Group A05BA contents

Code
Title
Arginine glutamate
Silymarin
Citiolone
Epomediol
Ornithine oxoglurate
Tidiacic arginine
Glycyrrhizic acid

Active ingredients in A05BA

Active Ingredient
Description

Silymarin is a plant-derived flavonoid from the plant Silybum marianum. The main component of the silymarin complex is silybin, which is a mixture of two diastereomers A and B in approximately 1:1 proportion. The drug possess hepatoprotective and antioxidant activity. The hepatoprotective effect is due to stimulation of synthesis of structural and functional proteins and phospholipids, as well as acceleration of the regeneration of hepatocytes. Antioxidant effect is determined by interaction of bioflavones with free radicals in the liver and its detoxication. In such manner the process of peroxidation of the lipids is interrupted and further liver destruction is prevented.

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
DE